The proteins processed by the secretory pathway (secretome) are critical players in the development of multi-cellular eukaryotic organisms but have yet to be comprehensively studied at the genomic level.
INTRODUCTION
Secreted proteins, including ligands and receptors, are critical to both short-and long-range intercellular signaling during the development and growth of multi-cellular organisms. Additionally, membrane proteins mediate cellular responses to a myriad of environmental cues. The development of embryos, and the differentiation of tissues important to animal production and vertebrate reproduction, respond to both intrinsic and external signals, a response likely regulated by secreted proteins. Functional understanding of these types of proteins could provide insight into diverse sets of biological processes critical to agricultural animal performance and human disease; these proteins are a high-priority target for functional annotation.
As de®ned by Tjalsma (1), the term`secretome' applies to all proteins that are synthesized and processed through the secretory pathway, along with the protein secretion machinery. Many proteins are secreted by targeting the endoplasmic reticulum (ER) membrane by signal peptides, which, if Type-1, are on average 20 amino acids long in eukaryotes and are located at the amino terminus of nascent polypeptides (2) . The signal peptide of the nascent polypeptide is recognized by the signal recognition particle (SRP), a cytoplasmic ribonucleoprotein consisting of six different subunits and 7SL RNA. The nascent chain±ribosome±SRP complex associates with the SRP receptor on the ER membrane and SRP is released from the complex. At the ER membrane, the nascent chain± ribosome complex associates with the protein translocation channel. This channel provides a closed and aqueous environment through which the hydrophilic nascent peptide chain can be cotranslationally translocated. Following transport to the ER lumen, the signal peptide is cleaved from the protein at a peptide bond preceded by two small neutral residues (3). The protein then undergoes folding, modi®cation and transport from the ER to locations such as the plasma membrane, extra cellular space or organelles.
A publicly available secreted protein database would provide a source of protein targets for use in research on agricultural animal performance, embryonic development, and human disease. Three projects identifying secreted proteins in Candida albicans, mouse and human have recently been published. The C.albicans project computationally identi®ed soluble proteins that possessed N-terminal signal sequences and lacked transmembrane domains, GPI anchor sites and mitochondrial targeting sequences, from open reading frames (ORFs) obtained from the yeast genome (4) . Unfortunately, many eukaryotes genomes have not been sequenced and higher eukaryote genomes contain signi®cant intron splicing, causing problems in identi®cation of translation initiation sites, and creation of partial ORFs.
Grimmond et al. studied a subset of the mouse genome representing the portion of the secretome found in an EST database, which encodes proteins with signal sequences and (5) . This study avoided complications arising from partial ORFs by using the RIKEN RPS, fully sequenced, full-length cDNAs, a type of data not often available for other vertebrates. The human secretome project identi®ed a set of`novel' transcripts possessing signal peptides or transmembrane domains (6) . Neither study represented a comprehensive genome-wide scan for annotating the vertebrate secretome. These projects nevertheless demonstrate a broad interest in secretome databases and illustrate the need for methods that analyze ESTs and identify those encoding full-length proteins.
Prediction of secretory proteins in mammalian genomic and EST sequences has been reviewed (7) . It has been shown that secreted protein prediction programs have been designed to effectively identify signal peptides in full-length protein sequences (8±10). However, these programs were not designed to analyze partial ESTs and it is expected the accuracy of predictions would deteriorate. ESTs are dif®cult targets for signal sequence prediction because they have a high inaccuracy rate (»2%) and are intrinsically 3¢ biased (11) . Consensus sequence clusters such as NCBI UniGenes (12) and TIGR Gene Indices (13) provide increased sequence quality and length, but these sequences may still lack the correct 5¢ end.
In this study, we describe our computation of human and Fugu secretomes based on public proteomes. We combine internal processing steps with public prediction software to more fully-automate secreted protein identi®cation. We use these methods to predict secreted proteins in TIGR Porcine Gene Index. This large mammal model organism is used since we have access to porcine clones to validate our predictions using an assay for cell-free cotranslational translocation (CTT). The methods described in this study are speci®cally designed to accept partial ORFs and improve secreted protein predictions in eukaryotic transcriptomes.
MATERIALS AND METHODS

Sequence data
Four secreted protein sequence sets were constructed using Homo sapiens and Takifugu rubripes (Fugu) proteomes. (18) . Protein sequences predicted to be secreted by TargetP, con®gured for non-plant analysis, with cleavage site prediction and winnertake-all selection, were assigned to their respective secreted protein sequence set. Sequences unique to each human secreted protein sequence set were estimated by comparing a cumulative sequence set (three human secreted protein sequence sets appended together) to itself using BLAST. Sequences matching only with themselves, at a threshold of È 1e ±10 (19) , were classi®ed as unique.
Secreted protein identi®cation
Secreted protein identi®cation is carried out in a multi-step process involving sequence comparison to reference secreted protein sequence sets, prediction of signal peptides, identi®-cation of putative start codons and N-terminal alignments. First, the target sequence set is compared to each reference secreted protein set using NCBI BLAST v2.1.2 (20) , with a selection threshold of 1e ±10 . All other parameters have default values. Target sequences possessing at least one homolog meeting the selection threshold are placed in a homolog sequence set; one homolog set is created for each reference set. The nucleotide sequences in the homolog sets are translated to protein sequences using BioPerl's CodonTable module (21) . The frame used for this translation corresponds to that used to align with the highest scoring homolog of each reference set. Each homologous sequence set was independently subjected to signal peptide prediction, translation start codon identi®cation and N-terminal alignment. Signal peptide prediction was performed by TargetP 1.01 Server, using default parameters (18) . Sequences predicted to contain a signal peptide in the ®rst 125 N-terminal amino acids of each target protein sequence made up the signal peptide positive sequence set. Target sequences were also analyzed for the presence of at least one`ATG' in the ®rst 150 5¢ base pairs, without reference to ATG context. Those sequences containing a putative start codon made up the ATG positive sequence set. N-terminal alignments of target protein sequences with their homologous reference secreted proteins were carried out using an index residue pair obtained from the BLAST output (Fig. 1) . The index residue pair is the ®rst reported sequence positions in the BLAST high-scoring pair alignment. Relative to the index residue pair, an N-terminal offset was calculated for the sequence pair. Target sequences with offsets less than or equal to a designated threshold (50 amino acids) made up the N-terminally aligned sequence set.
For each reference set, target sequences belonging to the signal peptide positive sequence set, the ATG positive sequence set and the N-terminally aligned sequence set, comprise the putative secreted protein sequence set. All putative secreted protein sequence sets were combined, and redundant sequences were removed, to create a non-redundant, putative secreted, protein set.
Test sequence selection
We selected putative secreted protein sequences containing at least one USDA Meat Animal Research Center (MARC) clone in the ®rst 35 nucleotides of the parent TIGR consensus sequence, since these clones were available to us to use in the CTT assay. To increase the utility of the test sequences for further comparative and functional studies, they were enriched in proteins with unknown function, based on homology (BLAST threshold of E`1e ±10 ) to proteins in the ENSEMBL human proteome dataset. 
ENSEMBL-based annotation
Putative secreted protein sequences were compared to the ENSEMBL known human peptide dataset version 15.33, to further annotate the sequences and estimate the number of novel sequences identi®ed. The two datasets were compared using BLAST (E`1e ±10 ). Protein annotation for their best human homolog was obtained from the ENSEMBL Description Field. Sequences were considered to have unknown function when the Description Field contained`No Description'.
Cotranslational translocation (CTT)
Clones from MARC 1PIG and 2PIG cDNA libraries (22) that were predicted to encode secreted proteins were grown overnight at 37°C in 1Q LB broth, 50 mg/ml carbenicillin. Plasmid DNA was isolated using standard alkaline lysis. To verify identity, each clone was 5¢-end sequenced and compared using pairwise BLAST to its GenBank EST entry. Transcription and translation reactions were carried out using Sp6 TNTâ Quick Coupled Transcription/Translation Systems (Promega, Madison, WI). Each reaction contained 20 ml of TNTâ Quick Master Mix, 2.0 ml of [ 35 S]methionine (1000 Ci/ mmol at 10 Ci/ml) (Amersham, Little Chalfont, UK), 0.5 mg of plasmid DNA, 0.5 ml of Promega Canine Pancreatic Microsomal Membranes (Promega) and nuclease-free water to a ®nal volume of 25 ml. Reactions were incubated for 90 min at 30°C. After the incubation, a 2.5 ml aliquot was removed (pre-protease total) and prepared for SDS±PAGE analysis to assess whether the cDNA produced a protein product.
The remainder of the reaction was incubated for 30 min on ice at 1 mg/ml proteinase K, and then quenched with 1 ml of Complete Proteinase Inhibitor EDTA free (Roche, Indianapolis, IN) at a concentration of one tablet per 300 ml of water. After a 15 min incubation on ice in the presence of the inhibitor, the entire reaction was diluted to 150 ml at a ®nal concentration of 110 mM KOAc, 20 mM K±Hepes, and 2 mM Mg(OAc) 2 [KHM]. The entire reaction mixture was then placed on a 0.5 M sucrose/KHM cushion and centrifuged at 40 000 r.p.m. (68 000 RCF) for 5 min at 4°C in a Beckman Optima TLX Ultracentrifuge in a TLA 100.3 rotor.
Three different fractions were processed for SDS±PAGE analysis from each sample; pre-protease total, pellet and supernatant. The presence of protein in the pre-protease sample indicated the cDNA was effectively transcribed and translated. Secreted proteins would be expected in the pellet, since they are protected from Proteinase K in the lumen of microsomes. Proteinase K treatment of the supernatant fraction was expected to degrade any non-secreted proteins or secreted proteins not cotranslationally translocated, possibly synthesized by the surplus of translation components in the reactions. SDS sample buffer was added to all fractions to a concentration of 2% SDS, 66 mM Tris, 4 M urea, 0.01% bromophenol blue and 5% BME. Pre-protease, supernatant and pellet fractions (2, 1 and 11%) along with 6 ml of Kaleidoscope Protein Standards (Bio-Rad), were resolved on a 4±10% gradient Ready Gel (Bio-Rad) at 150 V for~45 min. Gel running buffer was composed of 27 mM Tris, 190 mM glycine, 5.4 mM NaN 3 and 0.1% SDS. Gels were ®xed in 90:5:5 water, isopropyl alcohol and glacial acetic acid for 10 min followed by a 1 h treatment with Auto¯uor (National Diagnostics, Atlanta, GA), dried, exposed to X-ray ®lm overnight, and developed.
RESULTS
Reference secretome
Secreted protein sequence sets were constructed from full length human and Fugu protein sequence sets. These protein sets composed between 13 and 20% of the respective protein sequence sets (Table 1) and are available as Supplementary Material. Three human protein sequence sets were analyzed to maximize proteome coverage. Each set introduced unique (as de®ned in Materials and Methods) sequences into the human secretome. The IPI Human secreted protein sequence set contained 14.9% unique sequences, NCBI GenScan, 23.2% unique sequences, and NCBI RefSeq, 3.6% unique sequences. These were combined to create a human secretome containing 10 688 non-redundant protein sequences. 49% of the 5310 sequences in the Fugu secretome had no homolog in the human secretome.
Porcine secretome analysis TIGR Porcine Gene Index, release 4.0 was analyzed using methods presented in Secreted Protein Identi®cation. 3934 (25.2%) of the porcine nucleotide sequences are homologous to at least one secreted protein in the reference sequence sets, 22.6% homologous to a human protein and 13.6% homologous to a Fugu protein ( Table 2) . Inspection of the homologous porcine sequences shows that 3422 (87.0%) possess an ATG (putative start site) within the ®rst 150 5¢ bases. Following best-hit frame translation, 1487 (37.6%) of the porcine proteins aligned with their homolog at the Nterminus, within the designated threshold. 626 (16.2%) of the homologous protein sequences were predicted to possess N-terminal signal peptides. Collapsing across all three criteria 352 (9%) of the porcine sequences possessed a 5¢ ATG, acceptably aligned near the N-terminus, and possessed a predicted signal peptide. These porcine sequences, encoding putative, N-terminally complete, secreted proteins, make up 2.3% of the total porcine gene index and are available in the Supplementary Material. While most of the 352 sequences had homologs in more than one reference secreted protein sequence set, 38 had a homolog in only one set: 21 in IPI, eight in GenScan, two in RefSeq and seven in Fugu.
Annotation using human homologs
The 352 putative secreted porcine protein sequences were further annotated by BLAST comparison to the ENSEMBL known human peptide sequence set. ENSEMBL human homologs were identi®ed for 344 sequences (98%). Fortysix of the 344 were considered to have unknown function since the Description Field of their best ENSEMBL homolog contained`No Description'. The remaining eight did not have an ENSEMBL human homolog. One had a Fugu reference homolog, and the remaining seven had homologs from our, more inclusive, human reference secreted protein sequence sets.
We examined ENSEMBL homologs for the 352 sequences we identi®ed, speci®cally looking for annotation of TM domains and signal peptides. Eighty-six homologs contained annotated signal peptides. The ENSEMBL annotation for human homologs of 40 sequences selected for assessment by cell-free CTT is shown in Table 3 . Three of the 40 sequences did not possess a human homolog, while 17 were homologous with proteins lacking description and the remaining 20 (50%) were homologous with annotated human proteins. The sequences selected for cell-free testing were enriched for unknown function, to maximize the information gained by further study.
Assessment for cell-free CTT
A cell-free test for CTT was performed on 46 of the putative secreted proteins, selected from 190 of the 352 putative secreted proteins which contained a clone in MARC1PIG and MARC2PIG libraries within 35 bases of the consensus sequence 5¢ end. In order to provide insight as to the performance of our algorithm in de novo secreted protein identi®cation, our selection of 46 clones for CTT analysis was skewed towards proteins of unknown function. Six sequences failed to yield signi®cant translation product. Even under this rigorous challenge 34 of the 40 translated sequences (85%) were secreted according to cell-free CTT (Table 3) . Examples of positive and negative results are shown in Figure 2 .
DISCUSSION
Human and Fugu secretomes
We computed human and Fugu secretomes, containing ligands and receptors, through the analysis of publicly available proteomes by a signal peptide prediction program. The resulting human secreted protein sequence sets varied from 13 to 20% of their parent protein set (Table 1) . These were combined to create a total human secretome of 10 688 unique protein sequences. The Fugu secretome contained 5310 (14%) proteins. The human secretome had a 51% overlap with the Fugu secretome, less than the 61% overlap reported between mouse and human (5) . A greater disparity between human and Fugu is not surprising, since these are more evolutionarily distant vertebrates and indeed bracket both ends of the vertebrate lineage. Mouse sequences were not included in our study as they were not available when we began our experimental analysis of the porcine EST clones. However, our preliminary analysis of mouse data shows very close agreement in size for the computed mouse, human and Fugu secretomes. We conjecture that the secretomes for a majority of other vertebrates are composed of secreted proteins found in the logical union of the human and Fugu. The TC identi®er for 40 porcine sequences subjected to CTT validation, CTT results and ENSEMBL description ®eld annotation of their highest scoring human homolog, if present.
We selected three human protein sets for analysis in this study to maximize the coverage of the proteome since no`gold standard' human protein set exists. When the secreted protein sequence sets derived from each human protein set were compared, hundreds of unique sequences were found in each. Since sequence comparisons are performed against each reference secreted protein sequence set independently and equivalent value is given for homology with one or more proteins in any of the secretomes, there is negligible bias associated with this redundancy between the reference sets.
Signal peptide prediction on incomplete protein sequences
Nielsen et al. (23) state that signal peptide prediction on EST sequences when the start codon may not be present, and on sequences with N-terminal TM domains, can result in false positive signal peptide predictions. We developed a test case for this, truncating several known non-secreted proteins, and known secreted with and without internal TM domains. Our results con®rm Nielsen and coworkers' statement (Supplementary Material). Ab initio signal peptide prediction programs are designed to analyze full-length protein sequences and suffer reduced performance when used to analyze truncated, incomplete protein sequences, such as those derived from ESTs. Even though most proteins containing one or more TM domains also contain a SP, these misidenti®cations may lead to the incorrect assumption that the analyzed sequence is N-terminally complete. Since EST data are inherently fragmented, and even consensus sequences built from EST data are not necessarily full-length, SP predictions on these data are often not valid. We demonstrated the methods employed in this study are useful since they correctly predicted only those secreted proteins with N-terminally complete sequences.
Cell-free CTT
Forty-six sequences were tested for translation and translocation into pancreatic microsomes. Detectable protein was translated from 40 of the sequences; 34 of these were translocated into microsomes. This is a conservative validation method. It has a low false-positive rate, since proteins are protected from digestion only when completely translocated into microsomes. However, a receptor or other surfaceanchored protein could be translocated and still digested if a majority of the protein remains outside the microsome.
Six cDNAs were predicted to be secreted, but failed CTT. Two are highly homologous to known secreted proteins. The reason these proteins were not protected from proteolysis is not known, but the observation reveals the importance of annotating protein function by multiple techniques, and suggests possible false-negative results from the cell-free CTT assay. Consequently, this assay should be seen as a method for con®rmation, not rejection, of our predictions. Alternative methods would be needed to de®nitively determine whether those cDNAs failing cell-free CTT are in fact secreted (6, 24) .
Porcine secretome
Our analysis identi®ed 352 putative secreted sequences in the porcine gene index, representing the ®rst attempt to identify the porcine secretome. Extrapolating from the CTT results, 299 T 6 (95% con®dence interval) of the 352 sequences identi®ed are cotranslationally translocated. This extrapolation ignores any bias incurred from selection of sequences for validation, including the requirement for MARC clones in the 5¢ end of the consensus sequence assembly and enrichment with proteins of unknown function.
Analysis of the porcine data contains several examples where only one reference set contained a homolog to a putative secreted protein. Since each reference set was created based on different criteria, one may conjecture that putative secreted proteins with homologs in multiple sets are more likely to be true proteins. However, less well-characterized secreted proteins may have fewer homologs, and homologs in fewer reference protein sets.
Computationally derived protein sets such as GenScan, which do not use homology as a criterion for inclusion, may contain a higher percentage of conserved hypothetical or novel proteins. Two of the eight putative secreted porcine sequences only homologous to GenScan proteins were selected for CTT analysis. These sequences both exhibited CTT, and possessed ENSEMBL human protein homologs with unknown function. This supports the above possibility.
Of the 352 putative secreted porcine sequences, 98% possess human ENSEMBL homologs, con®rming the close homology of these two species. Only 86 of these ENSEMBL homologs were annotated to contain signal peptides, fewer than expected. Our methods to identify secreted proteins thus add value to protein annotation.
Assumptions
In our analysis, a protein identi®ed as secreted is required to have a homolog in the reference secreted protein sequence sets. Consequently, our methods do not identify putative secreted proteins lacking such homologs. This may occur because the protein sequence sets and derived reference secreted protein sets are incomplete, in part due to lack of quality 5¢ annotation of eukaryotic genomes. We miss proteins that have distant homologs or proteins that are unique to the query organism. Additionally, our approach does not identify proteins secreted by other mechanisms (25, 26) . Since the functional genomic studies that are being carried out on these putative secreted proteins are expensive and time-consuming, these studies should bene®t from N-terminally complete sequences and the minimization of false positives.
Comparison with other secretome projects
Our project was designed to develop a method for the analysis of all proteins targeted to the secretory pathway using type I signal sequences, including ligand and receptor molecules. We used the current, publicly available proteomes from Fugu and humans as they represent two opposite extremes of the vertebrate lineage. Depending on the protein sequence set used for our analysis, we identi®ed 13±20% of the human and 14% of the Fugu proteins as secreted. Although no similar comprehensive analysis using as template an entire vertebrate genome has been previously published for analysis of the secretome, two recent studies from mouse and human are noteworthy. Grimmond et al. (5) used a proprietary and full-length cDNA library for the identi®cation of candidate ligands encoded by the mouse secretome. Clark et al. (6) used human genomic and EST public and private data for the assessment of novel members of the human secretome. Neither example included a genomewide survey, but instead focused on the identi®cation of unannotated members of the secretome. Indeed, these datasets overlap and nicely complement the study described herein, offering an opportunity for the expansion of the reference protein dataset secretomes using distinct methodological approaches.
Future directions
Further development of our system offers the possibility of a more re®ned annotation of the vertebrate secretome. Development may include implementation of improved translational start site identi®cation, differentiation between secreted ligands and receptors, and more detailed homology selection criteria. These improvements will allow us to identify a larger percentage of a target secretome and better discriminate between proteins within this complex dataset.
The validated putative secreted proteins identi®ed by us in this study are well suited for analysis by comparative and functional genomic techniques. For example, eight of the 34 validated porcine sequences have likely zebra®sh homologs in the current EST dataset for this organism (data not shown), whose sequence information is suitable for morpholino-based knockdown' studies using the zebra®sh embryo (27) . The members of the secretome will continue to receive scienti®c emphasis in part because of the key roles these genes play in development and disease.
CONCLUSIONS
We have developed data freely available to the greater scienti®c community, including human, Fugu and porcine secretome databases. We have also developed methods for the analysis of eukaryotic EST sequences that reliably identify N-terminally-complete, secreted proteins, suitable for functional genomic studies. Our methods are useful for the analysis and annotation of ESTs, especially for organisms that do not have fully sequenced genomes.
